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Abstract: Possible sources of variation in non-polar secondary metabolites of Portieria 
hornemannii, sampled from two distinct regions in the Philippines (Batanes and Visayas), 
resulting from different life-history stages, presence of cryptic species, and/or spatiotemporal 
factors, were investigated. PCA analyses demonstrated secondary metabolite variation 
between, as well as within, five cryptic Batanes species. Intraspecific variation was even 
more pronounced in the three cryptic Visayas species, which included samples from six 
sites. Neither species groupings, nor spatial or temporal based patterns, were observed in 
the PCA analysis, however, intraspecific variation in secondary metabolites was detected 
between life-history stages. Male gametophytes (102 metabolites detected) were strongly 
discriminated from the two other stages, whilst female gametophyte (202 metabolites 
detected) and tetrasporophyte (106 metabolites detected) samples were partially 
discriminated. These results suggest that life-history driven variations, and possibly other 
microscale factors, may influence the variation within Portieria species. 
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1. Introduction  
Natural products, and in particular secondary metabolites, have been the focus of study in many 
marine macroalgae. Seaweeds interact with their environment utilizing a rich variety of secondary 
metabolites [1–4]. These chemical compounds have no explicit role in the internal metabolism of the 
organisms [1,5,6] but serve as defense mechanisms against grazers, competitors, fouling organisms 
and pathogens [7–9]. The compounds are localized in specialized cells, have relatively low molecular 
weights (<3000 Daltons), are structurally diverse, often halogenated, and exist in low abundance (often 
<1% of total carbon) [1,2,6,10–12].  
Secondary metabolites have drawn wide attention because of their pharmaceutical potentials, 
chemotaxonomic and ecological importance [13–16]. Macroalgae produce a wide range of compounds 
such as terpenes, phenols, fatty acids, lipopeptides, amides, alkaloids, terpenoids, lactones, pyrroles 
and steroids [9,15,17]. Red seaweeds belonging to the family Rhizophyllidaceae have been found to be 
especially rich in secondary metabolites, harboring a variety of halogenated monoterpenes. The 
tropical, Indo-Pacific genus Portieria (synonyms Chondrococcus and Desmia), is a prolific source of 
these halogenated compounds [11,12,18–24], about 80 of which have been isolated (Table S1). Among 
the most interesting of these compounds is halomon, a monoterpene with anti-tumor properties, 
isolated from samples collected in Batanes, Philippines [22,23]. However, the inconsistent availability 
of this compound from natural populations prevented further drug development.  
Previous studies have mainly focused on discovery and pharmaceutical potentials of chemical 
compounds in P. hornemannii. Only a few studies have addressed inter- or intraspecific variation in 
secondary metabolite composition. Puglisi and Paul [25] tested the carbon/nutrient hypothesis, which 
postulates that the secondary metabolites produced by a certain alga are dependent on the nutrient 
availability. They found that variation of ochtodene concentrations in P. hornemannii cannot be 
attributed to nitrogen and phosphorus availability but suggested instead that light was a contributing 
factor. Matlock et al. [24] demonstrated strong site-to-site differences, variation within populations, 
and limited evidence for temporal variation in apakaochtodene levels. Some authors have emphasized 
the necessity to genotype the organisms in order to better understand the mechanisms that regulate the 
production of specific natural products [5,26–28].We found evidence for a large number of cryptic 
species within Portieria in the Philippines [29], but the effect of intraspecific genetic variation in 
relation to secondary metabolites has not been tested to date. 
This study aims to understand if non-polar secondary metabolites of Portieria plants vary 
quantitatively or qualitatively between cryptic species and among life stage within species. We employed 
metabolite fingerprinting and multivariate analyses of chromatograms of extracts of samples collected 
in the Philippines. The large number of compounds produced by Portieria, the lack of commercial 
standards and the scarcity of compound identification resources (mass spectral databases) dedicated to 
marine secondary metabolites makes metabolite fingerprinting the most feasible analytical method to 
define variation between cryptic species and among life-history stages within species. In contrast to 
target analysis, metabolite fingerprinting does not separate individual metabolites, but instead compares 
spectra of whole extracts using multivariate statistics [30]. Metabolite fingerprinting is particularly 
useful for rapid classification of samples [31]. Our specific aims were to evaluate: (1) if there is 
variation of non-polar secondary metabolites between the gametophyte and tetrasporophyte life-history 
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stages of Portieria, (2) if metabolite variation is due to the presence of phylogenetically distinct cryptic 
species, and (3) if patterns of variation are observed on a geographical and temporal level. 
2. Results and Discussion  
2.1. Cryptic Diversity 
Phylogenetic analyses of 152 cox2-3 sequences revealed 12 clades of closely related sequences, 
preceded by long well-supported branches. Seven lineages include specimens from Batanes and five 
clades are restricted to the Visayas (Figure 1). These clades will further be regarded as species. Details 
on cryptic diversity and species delimitation are reported in Payo [29]. 
Figure 1. Phylogenetic tree reconstructed using Bayesian inference based on the 
mitochondrial cox2-3 spacer of Portieria specimens collected from Batanes (B) and 
Visayas (V) Islands in the Philippines. Branch support (posterior probabilities) ≥ 0.5 are 
indicated at the branches. The eleven clades represent cryptic lineages, likely equivalent to 
species. Species B34 and B38 were not included in the chemical analysis. 
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2.2. Identification of Compounds in Non-Polar Extracts 
Owing to the lack of standard compounds and public repositories of mass spectral data specific to 
marine metabolites, the identity of the compounds was investigated only by comparing the mass 
spectra and the Kovats retention indices to those deposited in publicly available databases (MassBase, 
Pherobase, Lucero Library and the free limited NIST database in the MS Search Program and 
AMDIS). Identifications were based on a minimum of 80% similarity of mass fragments. Using a 
retention index calculator [32], plant volatiles with the nearest Kovats Index (KI) to that of the 
compounds in the samples were retrieved. The KI used for compound identification is based on a DB5 
capillary column similar to the non-polar, low bleed HP-5MS column used for GC/MS in this study. 
The Lucero KI based identification was verified with the mass spectra and KIs listed in Pherobase. 
Comparison with mass spectra of compounds found in Portieria in the literature [11,12,33] did not 
reveal any positive identification. Examination of mass fragments did not show any similarity of 
components with that of halomon’s mass spectral fragments as reported by Egorin et al. [33]. 
2.3. Metabolite Fingerprinting 
2.3.1. Variation Between Life Stages 
Plants used for this study belonged to a single species V1B (Figure 1) and were collected on the 
same day from a single site in Bantayan, Dumaguete. A total of 202 non-polar compounds were 
detected from gametophytes and tetrasporophyte samples by GC-MS (Table S2). Using an external 
standard and the databases, the first peak of each sample (RT = 6.18 min) was confirmed as  
β–myrcene (Figure 2a). Of the remaining compounds, only 11% (22) were identified using NIST and 
MassBase. Based on the NIST and MassBase identifications, five compounds were monoterpenes. 
Examination of the patterns of parent ions showed ten halogenated compounds containing one Cl or 
one Br. Two hundred compounds had a KI ranging 993–1969. Some peaks with succeeding retention 
times shared the same KI but had a different mass spectra composition. NIST and MassBase did not 
share the same identification of peaks except for β-myrcene. 
KI for the last two peaks were not computed since it occurred later than the last alkane standard 
(C20 at 31.226 min) that was used for KI calculation. We also explored the potential of the Lucero 
library and Pherobase to identify compounds that Portieria might have in common with land plants. 
The Lucero library retrieved the nearest KIs of plant volatiles. Some of these identifications were 
verified at Pherobase, but mass spectra composition of the unidentified peaks was not similar to the 
spectra of the compound name retrieved from the database. Furthermore, we also tried to retrieve 
compounds with a certain KI and examined the corresponding spectra. β-Myrcene has a KI of 993.543 
in this study. Pherobase listed 991 and 994 as KIs for β-myrcene in a DB5 column. Nine compounds 
listed in the database have a KI of 993. 
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Figure 2. Portion of GC-MS total ion chromatograms of non-polar extracts of Portieria 
samples: (a) male gametophyte from Bantayan (Dumaguete), V1; (b) White Beach, 
Batanes, B21; (c) Liloan, V32. β-myrcene, a precursor of many halogenated monoterpenes, 
was detected only in the Bantayan specimens. Naphthalene is used as an internal standard. 
 
Figure 3. Frequency distribution indicating number of shared and unique non-polar 
secondary metabolites: (a) within life-history stage of species V1B from Bantayan, female 
(F), male (M) and tetrasporophyte (T); (b) among sites of species V32 collected in Sawang 
(SAW), Liloan (LIL) and Pagubagubaan (PAG). 
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The Lucero library lists KI 993 for β-myrcene. With the large number of metabolites retrieved, this 
method of verification proved cumbersome especially since Pherobase currently does not allow 
automated mass spectral and KI comparison. Of the 202 compounds detected, 155 compounds were 
present in the female samples, 102 in male plants and 106 in tetrasporophytes (Figure 3a).  
There were 55 compounds that were shared by all life stages. Sixty-three compounds were found 
exclusively in female gametophyte extracts, 15 in male gametophyte extracts, and 18 in tetrasporophyte 
extracts. There were 14 compounds common to male and tetrasporophyte extracts. The male and 
female gametophyte shared 18 compounds while female and tetrasporophyte shared 19 compounds.  
A precursor compound of the monoterpenes, myrcene, was detected in all of the life stages but not in 
all replicates. 
Figure 4. Principal component analysis of GC-MS standardized relative abundance 
datasets which includes the compounds detected in a 67-min run of Portieria extracts.  
(a) Male gametophyte (M1-2) samples are clearly discriminated occurring at the positive 
end of the plane while female gametophyte (F2-7) and tetrasporophyte samples (T1-2) are 
only partially discriminated by Factor 1; (b) Batanes dataset includes five cryptic species. 
The clustering of B35 replicates and the scattered pattern of B5 suggest variation in 
component compounds exists between species but at the same time suggested that variation 
within species can occur. 
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We applied a principal component analysis (PCA) on the standardized relative abundances to 
determine if metabolites differ among life stages (Figure 4a). The matrix contained 202 compounds 
(active variables) and ten samples (active cases: six female gametophytes, two male gametophytes, and 
two tetrasporophytes). All samples were collected on the same day from a single site, and belong to a 
single species. Figure 4a shows the projection of the cases on the factor plane. Factor 1 and factor 2 
accounts for 20.42% and 14.37% of the variation, respectively. Factor 1 clearly discriminated the male 
gametophytes from the others, whilst the female gametophytes and tetrasporophytes, although 
separated, were more closely aligned. Factor 2 does not discriminate between life stages but points 
towards additional variation within life stages. 
2.3.2. Variation Between Cryptic Species 
A total of 67 compounds were detected from nine samples (three technical replicates) by GC-MS 
(Table S3). These samples belonged to the five species B8, B5, B21, B33 and B35, as determined by 
DNA sequence analysis. A sample consists of pooled extract of eight individuals belonging to one 
species as verified by DNA analysis. β-Myrcene was not detected in any of the samples (Figure 2b). 
Unfortunately the three databases used (NIST, MassBase, Lucero library) did not give identical 
identifications of compounds. NIST identified four compounds appearing at different times as  
2,2-dimethyl-3-hexanone. Comparison of mass spectra with MassBase resulted in the retrieval of 
straight and branched alkanes and alkenes. Compounds with retention times from 8.11 to 30.69 min 
had retention indices from 1065 to 1965. No KIs were computed for the rest of the compounds. 
Comparison of computed KIs with those in the Lucero library indicated compounds from these 
samples contained monoterpenes, sesquiterpenes, esters, fatty acids and alcohols. NIST, MassBase and 
the Lucero databases did not share the same identification of compounds. Visual examination of parent 
ions showed only two compounds to be halogenated containing either one Cl or one Br. 
Table 1. Frequency of compounds that are unique to or common to several species of 
Portieria found in Batanes. Values in parenthesis indicate total number of compounds 
found in a species, while 1 indicates presence and 0 absence of a compound. 
B21 (49) B33 (51) B35 (60) B8 (57) B5 (57) Frequency (67) 
0 0 0 1 0 1 
0 0 1 1 0 3 
0 0 1 1 1 3 
0 1 0 0 0 1 
0 1 0 1 0 2 
0 1 1 1 0 1 
0 1 1 1 1 7 
1 0 1 0 1 3 
1 0 1 1 0 2 
1 0 1 1 1 4 
1 1 0 0 1 2 
1 1 0 1 1 1 
1 1 1 0 1 4 
1 1 1 1 1 33 
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The number of compounds detected varied between the five species (Table 1) and among biological 
replicates. Species B35 had the highest number of compounds detected (60/67), species B33 contained 
51/67 compounds detected, species B8 and B5 both had 57/67 compounds detected and species B21 
had the least number of compounds (49/67). There were 21 compounds that were detected in all nine 
samples, while 33 compounds were present in all five species. 
To detect distinct groupings, we conducted a PCA based on the standardized relative abundances of 
the nine samples using the 67 compounds as variables (Figure 4b). The first principal axis accounted 
for 27.4% of the variance while the second 16.0%. Plotted scores from the PCA did not show distinct 
interspecific clusters. The largest variation was displayed by specimens belonging to species B5. 
2.3.3. Spatial and Temporal Variation 
Six sites in the Visayas (Sawang, Pagubagubaan, Dapdap, Siaton, Liloan and Bantayan (Dumaguete); 
n = 44) were sampled from 2007 to 2009 and investigated using Spectconnect to determine if 
seasonality or geography explained the variation in secondary metabolites. A total of 33 compounds 
were detected from these samples (Table S4), however, β-myrcene was not detected (Figure 2c). As in 
previous datasets, the three databases (NIST, MassBase, Lucero library) used did not give identical 
identifications of compounds. Comparison of mass spectra with MassBase resulted in the retrieval of 
eleven compounds, most likely straight and branched alkanes and alkenes. Many of the peaks detected 
eluted later than the standard, icosane (C20), hence were not included. Comparison of computed RIs 
with those in Lucero library retrieved the following compound classes: monoterpenes, sesquiterpenes, 
esters and fatty acids. NIST library identified two compounds, 3-hexanone, 2,2-dimethyl- and disilane. 
No halogenated compounds were detected. 
Figure 5. Principal component analysis of GC-MS standardized relative abundance 
datasets for detecting possible spatial and temporal patterns in: (a) the Visayas species; 
(b) the Visayas samples belonging to species V32. Letters indicate sampling site (DAP: 
Dapdap; PAG: Pagubagubaan; SAW: Sawang; SIA: Siaton) and numbers indicate month 
and year of sampling. 
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Figure 5. Cont. 
 
PCA was conducted using the standardized relative abundance file generated by Spectconnect  
(n = 44) using the 33 compounds as variables (Figure 5a). The first and second PCs accounted for 
17.87% and 17.78% of the variance, respectively. No clear groupings could be deduced based on 
species, sampling period, or sampling site. Most of the samples clumped except for one Siaton and two 
Bantayan samples, which were clearly separated from the rest. A PCA excluding these three samples 
slightly spread the rest of the samples but likewise did not show any recognizable clusters (Figure 5a). A 
separate PCA analysis was conducted on samples belonging to the same species, V32, from Sawang, 
Pagubagubaan, and Liloan (Figure 5b). The first and second PCs accounted for 21.36% and 14.96% of 
the variance, respectively. Again, no clusters based on site or period of collection were detected. 
2.4. Patterns of Secondary Metabolite Distribution 
Distribution of secondary metabolites in marine macroalgae exhibit macroscale and microscale 
patterns [34]. Macroscale patterns include global patterns within or across algal taxa, patterns within a 
specific habitat, and patterns correlated with biotic and abiotic factors. Microscale patterns are related 
to molecular and biochemical processes within an algal thallus, the spatial distribution of compounds 
within an algal thallus and temporal responses (short- and long-term responses). In Portieria neither 
macro- nor microscale patterns of secondary metabolite variation have been fully explored.  
Although three decades of studies have been dedicated to the isolation of new compounds only two 
have investigated the variation of these, specifically ochtodene and apakaochtodene A and B [24,25]. 
However, a possible drawback related to these studies is the fact that individual compounds are not 
mutually independent but are linked via biological pathways as is the case for β-myrcene, which is the 
likely precursor of many monoterpenes [35], and whose presence influences the presence or absence of 
other halogenated monoterpene components. Hence in order to understand general or specific 
metabolite patterns, knowledge of the presence and absence of progenitor compounds is essential. The 
present study has successfully described the variation of the non-polar secondary metabolites of 
Portieria on a macroscale level using metabolite fingerprinting. 
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Reports on intraspecific variation of secondary metabolites in macroalgae have been based on 
variations within individuals, between individuals of a population and among geographically isolated 
populations [36,37]. Our results suggest substantial intraspecific variation among the life-history 
stages of Portieria. Male gametophytes form a clearly distinct group, while a partial discrimination 
was detected between female gametophytes and tetrasporophytes (Figure 4a). Furthermore, our results 
show that female gametophytes are chemically richer in terms of the number of secondary metabolites 
(Figure 3a), possibly providing protection to the carposporophyte from grazers. Many of the 
compounds detected appear to occur exclusively to a certain life-history stage while a relatively small 
group of compounds is shared among life-history stages. Similarly, male gametophytes of 
Asparagopsis armata were found to have lower concentration of the secondary metabolite bromoform 
compared to female gametophytes [37]. It has also been observed that the carposporophyte phase of A. 
armata was the least consumed life-history phase by the seahare, Aplysia parvula [37]. Likewise, in 
the brown alga Dictyota menstrualis, female gametophytes were found to produce more diterpenes 
compared to the other life-history stages [38]. 
Comparative analyses of the five cryptic species from Batanes (B5, B21, B33, B35, and B8) 
showed variation between, as well as within species (Figure 4b). Intraspecific variation is even more 
pronounced in the Visayas dataset (Figure 5). Neither species specific nor spatio-temporal patterns 
were evident. 
In addition, a separate PCA including only specimens of species V32 (Figure 3b) did not elucidate 
patterns based on collection site or period. The results suggest that life history related variations 
combined with microscale factors have a large influence on the variation within Portieria species. 
Pelletreau and Targett [34] pointed out that the existence of inducible and activated defenses 
complicates the search for universal patterns of secondary metabolites and continues to highlight the 
importance of localized phenomena. We conducted a preliminary grazing experiment in outdoor  
flow-through aquaria to assess the influence of the herbivore (Aplysia) on the production of 
metabolites in Portieria. However, these efforts were beset by two factors: death of plants due to high 
water temperature and continuous development of microscopic Aplysia larvae on field collected plants 
undergoing acclimatization. Future grazing experiments will attempt to eliminate these factors. In 
addition more extensive sampling should confirm the patterns observed during the present study. 
Finally, there was difficulty in achieving unequivocal identification of compounds in this study 
unveiling the need for mass spectral and KI databases dedicated solely to marine secondary 
metabolites. Such repositories will assist in the identification of previously reported compounds for 
investigations mainly focused on rapid detection and understanding of chemical patterns in marine 
organisms. In doing so, future studies will not just be focused in isolating and naming novel 
compounds as had been the trend in Portieria but will also seek to answer questions of biological or 
ecological relevance. Furthermore, the presence of cryptic species in Portieria highlights the need to 
genotype organisms ensuring that correct species identification is correlated with metabolite fingerprint, 
enabling more targeted approaches in future studies. 
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3. Experimental Section  
3.1. Collection and Storage 
Field samplings were performed at different periods from several sites in the Philippines (Figure S1). 
Plants were collected by snorkeling and SCUBA, diving depths ranging from 1–20 m. For secondary 
metabolite characterization of the different life-history stages of Portieria, plants were collected 
randomly from Bantayan near Dumaguete (Figure S1c) on December 29, 2009. To allow both chemical 
characterization and life-history stage verification plants were blotted dry and stored over silica. 
Plants for secondary metabolites analysis between species were collected from four sites in Batanes 
(Basco, White Beach, Coral, and in Chavayan) (Figure S1a,b) on April 23–26, 2009. Plants were 
preserved in 95% ethanol in the field and stored at −23 °C afterwards. Sampling for seasonal and 
spatial comparison of secondary metabolites were conducted from six sites in the Central Visayas 
(Dapdap, Siquijor, Siquijor; Pagubagubaan, San Juan, Siquijor; Sawang, San Juan Siquijor; Bantayan, 
Dumaguete, Negros Oriental; Siaton, Negros Oriental; Liloan, Santander, Cebu (Figure S1a,c) from 
2007 to 2009. For the first four sites, plants were collected on a monthly basis when present and when 
abundant enough to afford a good amount for extraction. For sites close to the Silliman Marine 
Laboratory, plants were immediately packed and stored at −23 °C upon arrival. When immediate 
freezing was not possible, plants were preserved in 95% ethanol in the field and stored at −23 °C. 
Frozen plants were rinsed in freshwater or in ethanol and blotted dry. 
As Portieria cannot be distinguished morphologically, species identification was based on DNA 
sequence data (see below). For DNA characterization, thallus clippings were collected from specimens 
and stored in silica while in the field. 
3.2. Extraction 
3.2.1. Life-History Stages Comparison 
Portieria has a tri-phasic isomorphic life history which includes free-living haploid male and female 
gametophytes, a diploid carposporophyte attached to and dependent on the female gametophyte, and a 
free-living diploid tetrasporophyte. Silica-dried specimens were examined under the microscope and 
segregated into different life-history stages (male gametophytes, female gametophytes, and 
tetrasporophytes). Biological replicates, each about 1 gram dry weight, were prepared for every  
life-history stage. Tissues were ground using mortar and pestle, dissolved in 6 mL dichloromethane 
(DCM) containing 50 µg·mL−1 naphthalene, and vortexed for a few seconds. The DCM extracts were 
allowed to stand at room temperature for 24 h in screw-cap tubes. The extracts were decanted and 
transferred to air tight screw-cap tubes and stored at −23 °C. The tissues were steeped in DCM for 
another 24 h. First and second extracts of a sample were pooled and filtered using Whatman GF/C. 
The combined extracts were loaded onto pre-conditioned SPE tubes containing 10 g of silica (Silicycle 
SiliaFlash® G60, 60–200 μm, 60 Å). Non-polar compounds were eluted using 12 mL hexane. The 
eluate was concentrated to 0.5 mL under N2 gas. Three 100 µL replicates were taken from this stock 
and used as technical replicates in the GC-MS analysis.  
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3.2.2. Species Comparison 
The samples were extracted individually. Tissue was ground using a mortar and pestle and extracted 
twice in 6 mL DCM overnight. Extracts were pooled, loaded onto 2 g silica and eluted using 6 mL of 
hexane. Eluates of eight samples belonging to the same species, approximately weighing 10–26 g, 
were pooled and evaporated down to 100 µL. To assess consistency in the GC-MS analyses, three 
technical replicates were prepared for each sample.  
HPLC solvents for extraction and chromatography (DCM and n-hexane) were sourced from 
Mallinckrodt or HiperSolv Chromanorm). Naphthalene (Fisher) and β-myrcene (Sigma) were used as 
internal and external standards, respectively. 
3.2.3. Seasonal and Spatial Comparison 
For seasonal analysis, plant material was ground using mortar and pestle. Twenty grams of ground 
material was extracted in 20 mL DCM for 24 h at room temperature. The material was extracted a 
second time in 20 mL DCM and the extracts were pooled. To measure the amount of green oil that was 
generated, one of the two pooled extracts was evaporated to dryness using nitrogen. The oil was 
weighed and redissolved in 20 mL DCM. The other extract was evaporated down to 20 mL. Both 
extracts were loaded in SPE columns containing 10 g of silica (Silicycle SiliaFlash® G60, 60–200 μm, 
60 Å). Non-polar compounds were eluted from the column with 20 mL hexane and again reduced to 
100 µL. A separate aliquot of ground plant tissue was used to determine dry mass. 
3.3. Phylogenetic Analysis 
Assignment of the sampled specimens to cryptic species was based on phylogenetic analysis of the 
mitochondrial cox2-3 spacer region. The phylogeny includes specimens collected from five sites 
(Basco, Chanaryan, Coral, Mahatao, Chavayan) in Batanes and six sites (Dapdap, Siquijor; Sawang, 
San Juan, Siquijor; Pagubagubaan, San Juan, Siquijor; Malo, Siaton; Bantayan, Dumaguete;  
Liloan, Santander) in the Visayas, Philippines. Species delineation follows the rational outlined in  
Payo et al. [29]. DNA extraction, PCR amplification, sequencing and sequence alignment were 
performed as described in Payo et al. [29].The alignment of 152 Portieria sequences was 345 bp long. 
Bayesian inference (BI) of phylogeny was performed using MrBayes v3.1.2 [39] under a GTR + I + Γ 
model as determined by jModelTest [40]. BI analyses consisted of two parallel runs of three 
incrementally heated chains and one cold chain each, and 3 million generations with sampling every 
1000 generations. A burnin value of 750 was determined using TRACER V1.4 [41]. 
3.4. Metabolite Analysis, Data Processing and Multivariate Analysis 
3.4.1. GC-MS Analysis 
GC-MS analyses of the non-polar eluates were performed using an Agilent 6890 gas chromatograph 
and Agilent 6973 mass selective detector. Sample injection volume was 1 μL. Split injection with a 
split ratio of 20:1 was used. The carrier gas was helium with a total flow rate of 72.7 mL·min−1 and 
26.20 psi column head pressure. Compounds were separated using a 30 m × 0.25 mm HP-5 MS  
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non-polar capillary column (Hewlett-Packard, 5% phenyl methyl siloxane, 0.25 μm thickness) for a 
run time of 67 min. under the following oven temperature program: 50 °C initial held for 2 min, then 
increased at a rate of 5 °C·min−1 to 300 °C, held for 15 min. The spectrometers were run in  
electron-impact mode with ionization energy of 70 eV and an ion source temperature ranging 230–250 °C. 
The scan range was set to detect masses 50–500 amu. 
3.4.2. GC-MS Data Processing 
The software AMDIS [42] was used for peak identification and deconvolution of the 
chromatogram. This method calculates and retrieves pure (background-free) mass spectra from raw 
GC-MS data files based from the parameters indicated by the user. The following parameters were 
used for all of the analyses: medium shape requirement, medium sensitivity, and medium resolution. 
The ELU files generated from AMDIS were submitted for analysis using Spectconnect [43] to generate 
matrices of component peaks (relative abundance, retention time, integrated signal and base peak). 
3.4.3. Compound Identification 
In the absence of pure standards of compounds previously isolated from Portieria (except for  
β-myrcene), we used KI’s, freely available mass spectral databases to determine identity of component 
peaks, and literature. We computed the Kovat’s or retention index of each peak using the retention 
times of alkane standards C8–C20 and the Retention Index Calculator [32]. The retention index is 
derived from the interpolation (usually logarithmic), relating the adjusted retention volume (time) of 
the sample component to the adjusted retention volumes (times) of two standards eluted before and 
after the peak of a sample component (IUPAC definition). The calculated KI was automatically 
compared to the KI’s of compounds stored in the built-in library of the calculator. Mass spectra of 
component peaks were compared to compounds retrieved from MassBank [44], Pherobase [45] and the 
limited version of the NIST library in the MS Search Program and AMDIS. Mass spectra of 
components were inspected for similarity with those of the characteristic mass signals of components 
published in [11,12,33]. 
3.4.4. Data Standardization, Metabolite Fingerprinting and Multivariate Analyses 
Relative abundance matrices generated from the Spectconnect analyses were used for statistical 
analyses. A matrix contains relative abundance values of all detected components across all samples 
included in the analysis. The data were standardized by obtaining a ratio between the relative 
abundance of a component per replicate (or sample) and the total of all components per replicate (or 
sample). The ratios obtained among the technical replicates were subsequently averaged. Principal 
component analysis was performed using Statistica 7.0 (StatSoft Inc., Tulsa, OK, USA) on each 
dataset to detect any pattern or groupings based from the variables which are the component compounds. 
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4. Conclusions  
Portieria species in the Philippines are a rich source of secondary metabolites. This diversity in 
secondary metabolites amounts to at least 302 various compounds. The majority of which are exotic, 
remain undescribed and therefore are not available in natural product databases. Our study demonstrates 
that metabolic fingerprinting presents a practical approach to disclose intra- and interspecific patterns 
of secondary metabolites. Variation in secondary metabolites occurs between, as well as within, 
Portieria species. Preliminary results, based on a relatively small sample size, demonstrate that 
extensive intraspecific variation in secondary metabolites occurs between life-history stages. Female 
gametophytes (202 compounds) are chemically richer compared to that of the males (102) and 
tetrasporophytes (106). No spatio-temporal patterns were evident among the datasets. These results 
suggest that life-history driven variations and possibly other microscale factors may have an important 
influence on the variation of secondary metabolites within Portieria species. More exhaustive sampling 
is needed to confirm the life-stage specific metabolic fingerprints. In addition, to determine whether 
the intraspecific variation of the analyzed part of non-polar metabolome remains lower than the 
interspecific variation, it will be necessary to expand the taxon sampling across different cryptic species. 
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Supplementary 
Table S1. List of compounds isolated from Portieria (syn. Desmia and Chondrococcus) 
hornemannii, based on previous studies. 
Reference Cpd # Name Mol. Formula Description Specimen Source 
[18] 1 Myrcene C10H16 acyclic 
halogenated 
monoterpene 
Amami Is., Japan 
 2 7-chloro-myrcene C10H15Cl " " 
 3 7-bromo-myrcene C10H15Br " " 
 4 (Z)-10-bromo-myrcene C10H15Br " " 
 5 (E)-10-bromo-myrcene C10H15Br " " 
 6 (Z)-10-bromo-7-chloro-
myrcene 
C10H14BrCl " " 
 7 (E)-10-bromo-7-
chloro-myrcene 
C10H14BrCl " " 
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 8 3-chloro-7, (Z)-10-
dibromo-myrcene 
C10H13Br2Cl " " 
 9 (Z)-10-chloro-3,7-
dibromo-myrcene 
C10H13Br2Cl " " 
 10 3-bromo-7-chloro-
myrcene 
C10H14BrCl " " 
 11 7-bromo-10-chloro-
myrcene 
C10H14BrCl " " 
 12 - C10H15Br cyclic halogenated 
monoterpene 
" 
[19] 1 chondrocole A C10H14BrClO " Hawaii 
 2 chondrocole B C10H14BrClO " Hawaii 
[46] 3 - C10H15Cl3Br2 acyclic 
halogenated 
monoterpene 
Black Point, 
Oahu, Hawaii 
 4 - C10H16Cl3Br " " 
 5 - C10H15Cl2Br " " 
 6 - C10H16Cl2Br2 " Halona Blowhole 
Is, Oahu, Hawaii 
 10 - C10H16Cl2Br2 acyclic 
halogenated 
monoterpene 
" 
 11 6-bromo-2-
chloromyrcene 
C10H15ClBr " Black Point, 
Oahu, Hawaii 
 12 chondrocole c C10H14Br2O   cyclic halogenated 
monoterpene 
" 
 13 - C10H15Cl3Br2 acyclic 
halogenated 
monoterpene 
Hawaii 
 14 Z-3-bromomethylene-
7-methyl-1,6-octadiene 
C10H16ClBr2 " Halona Blowhole 
Is., Oahu, Hawaii 
 15 - C10H14Br2Cl2 cyclic halogenated 
monoterpene 
" 
[47] 1 myrcene C10H16 acyclic 
halogenated 
monoterpene 
Kada Coast, 
Wakayama Pref., 
Japan 
 2 7-chloro-myrcene C10H15Cl " " 
 3 7-bromo-myrcene C10H15Br " " 
 4 3,7-dichloro-myrcene C10H14Cl2 " " 
 5 (Z)-10-bromo-3-
methoxy-α-myrcene 
C11H17OBr " " 
 6 (E)-10-bromo-3-
methoxy-α-myrcene 
C11H17OBr " " 
 7 3-bromo-7-chloro-
myrcene 
C10H14BrCl " " 
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 8 (Z)-10-bromo-1-
methoxy-myrcene 
C11H17OBr " " 
 9 (E)-10-bromo-1-
methoxy-myrcene 
C11H17OBr " " 
[48]  (−)-3-bromomethyl-3-
chloro-7-methyl-1,6-
octadiene 
C10H16BrCl " Trincomalee 
(Foul Point) Sri 
Lanka 
[49]  2-(1-chloro-2-
hydroxyethyl)-4,4-
dimethylcyclohexa-2, 
5-dienone: a precursor 
of 4,5-dimethylbenzo 
[b] furan 
- - - 
[20] 1 (2Z,6E)-1,8-dichloro-3-
chloromethyl-7-
methylocta-2,6-diene  
C10H15Cl3 acyclic 
halogenated 
monoterpene 
Rib Reef, Great 
Barrier Reef, 
Australia 
 2 (E)-1,2-dibromo-3-
chloromethylene-7-
methyloct-6-ene 
C10H15Br2Cl " " 
 3 (Z)-1-chloro-3-
chloromethyl-7-
methylocta-2,6-diene 
C10H16Cl2 " " 
 4 (Z)-1,6-dichloro-3-
chloromethyl-7-
methylocta-2,7-diene 
C10H15Cl3 " " 
 5 (2R*,3(8)E,4S*,6R*)-6-
bromo-2-chloro-1,4-
oxido-3,(8)-ochtodene 
C10H14BrClO epimeric bicyclic 
monoterpene 
" 
 6 (2S*,3(8)E,4S*,6R*)-6-
bromo-2-chloro-1,4-
oxido-3,(8)-ochtodene 
C10H14BrClO " " 
[50]  (Z)-3-bromo-8-chloro-
6-chloromethyl-2-
methylocta-1,6-diene 
(9,6-hydroxymethyl-2-
methylocta-2,8-dien-6-
ol  
- - - 
[21] 1 (2Z)-6-bromo-3-
chloromethyl-1,7-
dichloro-7-methylocta-
2-ene 
C10H16Cl3Br acyclic 
halogenated 
monoterpene 
Nelly Bay, 
Magnetic Island, 
Queensland, 
Australia 
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 2 (2Z,6E)-3-
chloromethyl-1-
chloroocta-2,6-dien-8-
al 
C10H14 OCl2 " " 
 3 3-methoxymethyl-6-
methoxyl-7-
methylocta-1,7(10)-
dien-3-ol 
C12H22 O3 " " 
 4 (2Z,6S)-3-
chloromethyl-1-
methylocta-2,7(10)-
dien-6-ol 
C11H19 O2Cl " " 
 5 (2Z,6S)-3-
chloromethyl-6-
methylocta-2,7(10)-
dien-1-ol 
C11H19 O2Cl " " 
[22] 1 halomon/6(R)-bromo-
3(S)-(bromomethyl)-7-
methyl-2,3,7-trichloro-
1-octene 
C10H15Br2Cl3 acyclic 
halogenated 
monoterpene 
Chanaryan, Batan 
Is., Batanes, 
Philippines 
 2 - C10H13Cl cyclic halogenated 
monoterpene 
Banilad, Bacong, 
Negros Oriental, 
Philippines 
[23] 2 isohalomon C10H15Br2Cl3 acyclic 
halogenated 
monoterpene; 
isomeric with 
halomon 
Chanaryan, Batan 
Is., Batanes, 
Philippines 
 3 - C10H14BrCl3 acyclic 
halogenated 
monoterpene 
" 
 4 - C10H14Br2Cl2 " " 
 5 - C10H14Br3Cl cyclic halogenated 
monoterpene 
" 
 6 - C10H14BrCl3 " " 
 7 - C10H13Cl3 " " 
 8 - C10H15BrCl2 acyclic 
halogenated 
monoterpene 
" 
 9 - C10H16Br2Cl2 " " 
 10 - C10H16BrCl " Halona Blowhole 
Is, Oahu, Hawaii 
 11 - C10H15BrCl " " 
 12 - C10H14BrCl cyclic halogenated 
monoterpene 
" 
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[8] 1 apakaochtodene A/ 
6(S*)-bromo-
1,4(S*),8(R*)-trichloro-
2(Z)-ochtodene 
C10H14Cl3Br cyclic halogenated 
monoterpene 
Apaka Point 
Beach, Guam 
 2 apakaochtodene B/ 
6(S)-bromo-1,4(S), 
8(R*)-trichloro-2(E)-
ochtodene 
C10H14Cl3Br cyclic halogenated 
monoterpene 
Gun Beach; 
Double Reef; 
Pago Bay; Guam 
[11] 1 myrcene/7-methyl-3-
methylene-1,6-
octadiene 
C10 H16O acyclic non-
halogenated 
monoterpene 
microplantlet 
culture, Double 
Reef NW Guam 
 2 10E-bromomyrcene/ 
E-3-bromomethylene-
7-methyl-1,6-octadiene 
C10H15Br  " " 
 3 10Z-bromomyrcene/ 
Z-3-bromomethylene-
7-methyl-1,6-octadiene 
C10H15Br  " " 
 4 10E-bromo-3-chloro-
α-myrcene/E-3-
bromomethylene-6-
chloro-1,7-octadiene 
C10H14BrCl " " 
 5 - C10H14Br2 " " 
 6 apakaochtodene B/ 
6(S)-bromo-1,4(S), 
8(R*)-trichloro-2(E)-
ochtodene 
C10H14BrCl3 cyclic halogenated 
monoterpene 
" 
 7 - C10 H16O non-halogenated 
monoterpene 
" 
 8 bromomyrcene isomer C10H15Br  halogenated 
monoterpene 
" 
 9 7-chloromyrcene/2-
chloro-3-methylene-7-
methyl-1,6-octadiene 
C10H15Cl " " 
 10  C10H14Cl " " 
 11 chloromyrcene 
derivative 
C10H16Cl " " 
 12 bromomyrcene isomer C10H15Br  " " 
 13 chloromyrcene 
derivative 
C10H14Cl " " 
 14 - C10H18Cl2 " " 
 15 - C15H18 O4 sesquiterpene " 
[13] 5 1,2-dibromoochtoda-
3(8),5-dien-4-one 
C22H12Br2O cyclic halogenated 
monoterpene 
Cape Zampa, 
Okinawa, Japan 
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 6 1-bromo-2-
chloroochtoda-3(8),5-
dien-4-one 
C10H12BrClO " " 
 7 1,2-dichloroochtoda-
3(8),5-dien-4-one 
C10H12Cl2O " Gushichan coast, 
Okinawa, Japan 
 8 (1Z)-1-bromoochtoda-
1,3(8),5-trien-4-one 
C10H11BrO " Cape Zampa, 
Okinawa, Japan 
 9 (1Z)-1-chloroochtoda-
1,3(8),5-trien-4-one 
C10H11ClO " " 
[12] 1 halomon/6(R)-bromo-
3(S)-(bromomethyl)-7-
methyl-2,3,7-trichloro-
1-octene 
C10H15Br2Cl3 acyclic 
halogenated 
monoterpene 
Tolagniaro, Fort 
Dauphin, 
Madagascar 
 2 - C10H13ClBr " " 
 3 - C10H14Cl2Br   " " 
 4   C10H15Br2Cl3 " " 
Table S2. Compound peaks detected from GC-MS analysis of samples used for 
characterization of the life history stages of P. hornemannii. Identifications based on 
comparison of either Kovat’s Indices (KI) of compounds retrieved from the Retention 
Index Calculator [37] or mass spectral comparison of compounds retrieved from NIST or 
MassBase. Asterisk (*) indicates compounds with parent ions showing halogenated mass 
spectral patterns. 
# Sample Base 
Peak 
 KI KI Based ID  Mass Spectra Based ID 
   RT (min)  Nearest 
KI 
Lucero et al. [37] NIST MassBase 
1 F6_2 93 6.1863 994 993/994 beta-myrcene/6-
methyl-5-hepten-2-ol 
b-myrcene b-myrcene 
2 T1_1 104 6.5874 1008 1007 α-phellandrene - - 
3 T1_2 104 6.5909 1008 1007 α-phellandrene - - 
4 M1_1 91 6.7685 1016 1017 α-terpinene Benzene,  
tert-butyl- 
4-
methylacetophenone 
5 F3_3 79 6.9501 1023 1024 r-cymene - - 
6 M1_2 79 6.9532 1023 1024 r-cymene - - 
7 M1_3 91 7.017 1026 1025 p-cymene carbonic acid 1-phenylpropan-2-
one 
8 M2_2 91 7.021 1026 1025 p-cymene - protopine 
9 F3_2 91 7.0387 1027 1025 p-cymene - N-Methyl-N-
propagylbenzylamine 
10 T2_1 57 8.0381 1063 1062 y-terpinene - - 
11 M2_2 132 8.8894 1089 1089 p-mentha-
2,4(8)diene 
- - 
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12 T2_1 117 9.5127 1110 1099 linalool - - 
13 F4_3 117 9.8874 1124 1123 chrysanthenone - - 
14 M1_3 117 9.9855 1128 1127 α-campholenal - - 
15 M2_2 91 10.2042 1136 1127 α-campholenal - - 
16 F2_2 91 10.2132 1136 1127 α-campholenal - Dimethirimol 
17 T2_1 119 10.4565 1145 1145 camphor - Benzimidazole 
18 M1_1 68 10.8826 1160 1158 isobomeol - - 
19 F7_3 68 10.8845 1160 1158 isobomeol - - 
20 T2_1 68 10.8866 1160 1158 isobomeol - - 
21 F3_3 68 10.8873 1160 1158 isobomeol - - 
 
22 F4_1 117 11.3242 1174 1171 ethyl-benzoate - - 
23 F4_1 50 11.5177 1180 1180 m-cymen-8-ol - - 
24 T2_2 127 11.5317 1180 1180 m-cymen-8-ol - - 
25 T2_3 134 11.7619 1188 1187 p-cymen-8-ol - - 
26 M2_2 105 12.0654 1197 1196 methylchavicol - 3-cyanopyridine 
27 F3_2 57 12.1827 1200 1203 n-decanal  3-Hexanone - 
28 F7_3 113 12.3674 1207 1207 verbenone - - 
29 M1_2 113 12.3831 1208 1207 verbenone - - 
30 T1_3 91 12.3874 1208 1207 verbenone - - 
31 M2_2 93 12.6294 1217 1217 trans-carveol - - 
32 M1_2 69 12.7588 1222 1219 trans-carveol - - 
33 M1_1 55 12.8397 1225 1229 nerol - - 
34 F7_3 67 13.1203 1236 1236 thymol methyl ether - - 
35 M1_1 79 13.1266 1236 1236 thymol methyl ether - - 
36 F5_2 93 13.127 1236 1236 thymol methyl ether - Beta-pinene;  
y-eudesmol 
37 M2_2 93 13.32 1243 1243 carvone - - 
38 T1_1 93 13.327 1243 1243 carvone 2-
chloropropionyl 
chloride 
- 
39 T2_1 93 13.3305 1243 1243 carvone - - 
40 
*(Br) 
F6_2 69 13.6916 1256 1256 geraniol - - 
41 M1_1 91 13.6953 1256 1256 geraniol  - 
42 F2_1 69 13.6967 1256 1256 geraniol -  
43 F5_1 69 13.6975 1256 1256 geraniol - - 
44 M2_1 91 13.9837 1266 1263 (E)-2-decenal - N-Methyl-N-
propagylbenzylamin
e 
45 F7_3 119 14.131 1271 1271 geranial - - 
46 F2_3 119 14.1354 1271 1271 geranial - - 
47 F3_2 69 14.4252 1281 1282 a-terpinen-7-al - - 
48 M2_3 69 14.4368 1281 1282 a-terpinen-7-al - - 
49 F5_1 91 14.6745 1289 1289 p-cymen-7-ol - - 
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50 T2_1 91 14.68 1289 1289 p-cymen-7-ol - - 
51 F6_3 149 14.9157 1297 1297 perilla alcohol - Benzoylcholine 
52 * 
(Cl) 
F6_3 131 15.0641 1302 1302 trans-ascaridole - 2-chloro-1-phenyl-
2-butene 
53 F6_1 166 15.3344 1313 1313 2E,4E-decadienal - 2-chloro-1-phenyl-
2-butene 
54 F6_3 81 15.5368 1320 1313 2E,4E-decadienal - - 
55 M2_2 81 15.5381 1321 1313 2E,4E-decadienal - - 
56 T1_2 81 15.5481 1321 1313 2E,4E-decadienal - - 
57 M2_2 67 15.6269 1324 1313 2E,4E-decadienal - 1-Adamantanamine 
58 M1_2 67 15.6354 1324 1313 2E,4E-decadienal - - 
59 F3_1 57 15.7447 1329 1339 d-elemene - - 
60 F2_1 57 15.7649 1329 1339 d-elemene - - 
61 M2_2 91 15.8827 1334 1339 d-elemene - - 
62 M1_2 91 15.8885 1334 1339 d-elemene - - 
63 M2_2 139 16.5157 1357 1357 eugenol - - 
64 F6_1 115 16.5278 1358 1357 eugenol - - 
65 M2_3 166 16.5392 1358 1357 eugenol - - 
66 M2_2 91 17.02 1375 1373 a-ylangene - - 
67 M2_3 91 17.0254 1376 1373 a-ylangene - - 
68 M1_2 91 17.0311 1376 1373 a-ylangene - - 
69 T2_1 127 17.403 1389 1389 isolongifolene - Imidazole-4-acetate 
70 T2_1 57 17.7476 1400 1399 1,7-di-epi-a-cedrene - - 
71 M2_2 79 17.7625 1401 1402 methyleugenol - - 
72 M2_3 127 17.7782 1402 1402 methyleugenol - - 
73 T2_2 67 18.1041 1415 1415 cis-a-bergarnotene - - 
74 T1_3 79 18.18 1418 1419 β-caryophyllene - - 
75 F6_1 79 18.1866 1419 1419 β-caryophyllene - - 
76 T1_1 79 18.1928 1419 1419 β-caryophyllene Pyridine - 
77 F5_1 79 18.1934 1419 1419 β-caryophyllene - camphene 
78 M1_2 79 18.1939 1419 1419 β-caryophyllene - - 
79 * 
(Br) 
F7_2 212 18.3193 1424 1420 β-caroyophyllene - - 
80 F6_2 210 18.4564 1429 1420 β-caroyophyllene - - 
81 M2_3 131 18.4673 1430 1420 β-caroyophyllene - - 
82 M1_1 67 18.5462 1433 1435 trans-a-bergamotene - - 
83 M1_2 67 18.5503 1433 1435 trans-a-bergamotene - - 
84 F2_2 133 18.6084 1435 1435 trans-a-bergamotene - - 
85 T2_2 69 18.6925 1439 1438 trans-a-bergamotene - - 
86 F3_3 69 18.6982 1439 1440 a-guaiene - - 
87 M2_3 69 18.7018 1439 1440 a-guaiene - - 
88 M1_1 91 18.7475 1441 1440 a-guaiene - - 
89 F4_2 69 18.8243 1444 1440 a-guaiene - - 
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90 F7_2 69 18.8273 1444 1440 a-guaiene - - 
91 T1_3 69 18.8306 1444 1440 a-guaiene - - 
92 F2_2 210 19.1226 1456 1455 a-humulene - - 
93 F3_3 133 19.3339 1464 1464 a-acoradiene -  
94 T2_2 105 19.4843 1469 1469 drima-7,9(11)-diene - - 
95 T2_1 105 19.4852 1469 1469 drima-7,9(11)-diene - - 
96 F7_2 131 19.4915 1470 1469 drima-7,9(11)-diene - - 
97 F5_1 91 19.6255 1475 1474 b-cadinene - - 
98 F6_3 91 19.7468 1479 1479 y-curcurnene -  
99 F2_1 91 19.7581 1480 1480 germacrene D - - 
100 F4_1 153 20.0567 1491 1491 cis-β-guaiene - - 
101 F4_1 153 20.0567 1491 1491 cis-β-guaiene - - 
102 F3_2 71 20.2111 1496 1495 a-zingiberene -  
103 F7_2 135 20.3621 1502 1499 a-muurolene - - 
104 F5_1 91 20.3727 1503 1506 d-selinene - - 
105 T2_1 91 20.3766 1503 1506 d-selinene - - 
106 F2_2 91 20.3829 1503 1506 d-selinene -- - 
107 F6_1 205 20.6221 1513 1513 g-cadinene - - 
108 F4_3 205 20.6237 1513 1513 g-cadinene - - 
109 F7_2 205 20.6252 1513 1513 g-cadinene - 5-bromo-4-
methoxyoct-1-ene 
110 T2_1 205 20.6278 1513 1513 g-cadinene p-Benzoquinone - 
111 F3_2 133 20.6781 1516 1514 sesquicineole - - 
112 F3_3 133 20.6803 1516 1514 sesquicineole - - 
113 F6_3 133 20.685 1516 1514 sesquicineole - - 
114 F5_1 69 20.8293 1522 1523 d-cadinene - -- 
115 F5_1 69 20.9154 1526 1525 eugenyl acetate - - 
116 F6_3 69 20.9158 1526 1525 eugenyl acetate - - 
117 F7_2 121 20.9204 1526 1525 eugenyl acetate - - 
118 T1_3 69 20.9227 1526 1525 eugenyl acetate - - 
119 F7_2 167 21.1103 1534 1533 cadina-1,4-diene1 - - 
120 T2_2 91 21.1498 1536 1538 a-cadinene - - 
121 F6_1 167 21.43 1547 1548 elemol - - 
122 F7_2 167 21.4346 1547 1548 elemol - - 
123 T1_3 69 21.467 1549 1549 elemol - -- 
124 F3_2 69 21.4709 1549 1549 elemol - - 
125 F7_2 91 21.598 1554 1552 elemicin - - 
126 F6_2 91 21.6852 1557 1557 germacrene B - - 
127 F5_1 91 21.6859 1558 1557 germacrene B - - 
128 F6_3 91 21.6869 1558 1557 germacrene B - - 
129 M1_1 91 21.6895 1558 1557 germacrene B - - 
130 F6_3 67 21.7268 1559 1557 germacrene B - - 
131 F7_2 133 21.8253 1563 1564 β-calacorene - L-Asparagine 
132 T1_1 91 21.8405 1564 1564 β-calacorene - - 
133 F7_2 167 22.0012 1570 1574 prenopsan-8-ol - - 
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134 T1_3 213 22.018 1571 1574 prenopsan-8-ol - - 
135 F6_3 132 22.0226 1571 1574 prenopsan-8-ol - - 
136 F6_3 153 22.0226 1571 1574 prenopsan-8-ol - - 
137 M1_1 91 22.3956 1586 1585 gleenol - - 
138 F2_2 133 22.5362 1591 1590 viridflorol - - 
139 F6_3 71 22.7179 1598 1590 viridflorol - - 
140 F3_2 71 22.7193 1598 1590 viridflorol - - 
141 F2_3 135 22.722 1598 1590 viridflorol - - 
142 F3_3 57 22.7547 1600 1607 b-oplopenone - - 
143 F3_2 57 22.7603 1600 1607 b-oplopenone - - 
144 F3_3 57 22.761 1600 1607 b-oplopenone - - 
145 F6_3 67 22.8782 1605 1607 b-oplopenone - - 
146 T2_2 68 23.0541 1613 1612 tetradecanal - - 
147 F4_3 148 23.2435 1622 1623 silphiperfol-6-en-5-
one 
- - 
148 F3_1 135 23.2485 1622 1623 silphiperfol-6-en-5-
one 
- - 
149 F5_3 91 23.52 1634 1633 y-eudesmol - - 
150 F4_3 91 23.5226 1634 1633 y-eudesmol - - 
151 F7_2 68 23.5261 1634 1633 y-eudesmol - - 
152 F7_2 68 23.5261 1634 1633 y-eudesmol - -- 
153 T2_2 68 23.5278 1634 1633 y-eudesmol - - 
154 F6_1 167 23.5309 1634 1633 y-eudesmol -  
155 F6_2 67 23.7239 1643 1642 cubenol - allylcy-anide 
156 T1_3 91 23.8325 1647 1646 a-muurolol - - 
157 F7_2 132 23.8759 1649 1646 a-muurolol - - 
158 F7_2 132 23.9988 1654 1653 a-cadinol - - 
159 F6_2 149 24.3377 1669 1668 bulnesol - - 
160 F7_2 149 24.3428 1669 1668 bulnesol - - 
161 F6_3 167 24.6091 1680 1682 a-bisabolol - - 
162 F6_1 57  24.6252 1681 1682 a-bisabolol - - 
163 F7_2 69  24.8113 1689 1686 8-cedren-13-ol - - 
164 F7_2 69  24.8207 1689 1686 8-cedren-13-ol - - 
165 F2_3 67  24.9282 1693 1686 8-cedren-13-ol - - 
166 F6_1 57  25.0854 1700 1686 8-cedren-13-ol - Heptadecane 
167 F7_2 91  25.3006 1710 1686 8-cedren-13-ol - - 
168 F3_2 71  25.3224 1711 1735 oplopanone - - 
169 F3_3 68  25.4814 1718 1735 oplopanone - - 
170 F6_3 67  25.7278 1730 1735 oplopanone - - 
171 F7_2 103 25.7292 1730 1735 oplopanone - - 
172 F2_1 67  25.7318 1730 1735 oplopanone - - 
173 F2_3 133 25.8305 1735 1735 oplopanone - - 
174 F3_1 117 25.8366 1735 1735 oplopanone - - 
175 F7_2 167 26.3223 1757 1761 benzyl-benzoate - - 
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176 T2_1 167 26.5838 1769 1761 benzyl-benzoate - 6-Methylmer-
captopurine 
177 F6_2 117 26.7333 1775 1789 8-a-acetoxyelemol - - 
178 T2_2 103 26.8111 1779 1789 8-a-acetoxyelemol - - 
179 F3_1 67  26.8577 1781 1789 8-a-acetoxyelemol - - 
180 F6_1 67  26.8599 1781 1789 8-a-acetoxyelemol - - 
181 F3_2 67  26.8671 1781 1789 8-a-acetoxyelemol - - 
182 T2_1 67  26.8697 1781 1789 8-a-acetoxyelemol - - 
183 * 
(Cl2) 
F6_1 103 26.8838 1782 1789 8-a-acetoxyelemol - - 
184 F3_1 103 26.8852 1782 1789 8-a-acetoxyelemol - - 
185 * 
(Br) 
F6_1 67  27.4286 1806 1798 nootkatone - - 
186 * 
(Br) 
F7_2 67  27.4342 1806 1798 nootkatone - - 
187 F2_1 67  27.4383 1807 1798 nootkatone - - 
188 F6_3 103 27.4961 1810 1798 nootkatone - - 
189 F6_1 67  27.5012 1810 1798 nootkatone - - 
190 F6_2 67  27.5676 1813 1827 isopropyl 
tetradecanoate 
- - 
191 F6_2 69  28.0351 1836 1827 isopropyl 
tetradecanoate 
- - 
192 F3_2 69  28.0387 1836 1827 isopropyl 
tetradecanoate 
- - 
193 F6_1 91  28.3153 1849 1867 flourensiadiol - - 
194 F3_2 149 28.735 1869 1867 flourensiadiol - - 
195 * 
(ClBr) 
F6_2 69  29.2918 1895 1878 hexadecanol - - 
196 F5_3 67  29.4766 1903 1927 methyl 
hexadecanoate 
- - 
197 T2_1 67  29.4889 1904 1927 methyl 
hexadecanoate 
- - 
198 F7_2 91  30.7705 1968 1999 eicosane - - 
199 T2_2 91  30.7753 1969 1999 eicosane - - 
200 F3_2 91  30.7855 1969 1999 eicosane - - 
201 T2_2 64  31.6475 - - - - - 
202 T2_2 129 38.661  -  -  - - - 
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Table S3. Compound peaks detected from GC-MS analysis of samples for evaluation of 
non-polar secondary metabolite patterns of 5 cryptic species of P. hornemanni found in 
Batanes, Philippines. Identifications based on comparison of either Kovat’s Indices (KI) of 
compounds retrieved from the Retention Index Calculator [37] or mass spectral 
comparison of compounds retrieved from NIST or MassBase. Asterisk (*) indicates 
compounds with parent ions showing halogenated mass spectral patterns. 
# Sample Base 
Peak 
  KI KI Based ID  Mass Spectra Based ID 
   RT 
(min) 
 Nearest 
KI 
Lucero et al. [37] NIST Massbase 
1 B4B 57 8.1122 1065 1062 y-terpinene - - 
2 B4C 69 8.7386 1085 1085 artemisia-alcohol - - 
3 B4C 57 9.1807 1098 1097 linalool - - 
4 B4B 71 9.1841 1098 1097 linalool - - 
5 B6C 57 9.4047 1106 1099 linalool 3-hexanone, 
2,2-dimethyl- 
2-methylbutane 
6 B4C 69 11.2515 1172 1171 ethyl-benzoate - - 
7- * 
(Cl) 
B3A 69 11.2560 1172 1171 ethyl-benzoate - - 
8 B4A 57 14.3547 1279 1277 trans-carvone-
oxide 
- 2,2-dimethylbutane 
9 B4B 57 14.3593 1279 1277 trans-carvone-
oxide 
- 3-ethylhexane 
10 B3B 57 14.5560 1285 1286 borneol-acetate -  
11 B3A 69 15.2678 1310 1306 undecanal - trans-4-octene 
12 B3A 57 15.6497 1325 1314 2E,4E-decadienal -  
13 B6B 57 15.6518 1325 1314 2E,4E-decadienal -  
14 B4A 71 16.5884 1360 1357 eugenol - 2-methylpentane 
15 B6C 57 17.8154 1403 1403 italicene - 2,2-dimethylbutane 
16 B3A 57 17.8289 1404 1403 italicene -  
17 B10 71 20.306 1500 1499 a-muurolene - Pentacosane 
18 B3A 57 20.4025 1504 1506 d-selinene - tripropylamine 
19 B4A 191 20.715 1517 1514 sesquicineole -  
20 B6C 57 21.0008 1529 1532 cadina-1,4-diene -  
21- * 
(Br) 
B3B 57 21.0024 1529 1532 cadina-1,4-diene - 1-octene 
22 B4A 69 21.5566 1552 1552 elemicin -  
23 B4A 57 25.1819 1704 1686 8-cedren-13-ol -  
24 B4B 71 25.4142 1715 1735 oplopanone - Hexacosane 
25 B4B 69 26.0498 1745 1747 6S-7R-bisabolone - 10-methyl-1-
dodecanol 
26 B4A 57 27.4031 1805 1798 nootkatone - 4-methyl-1-pentene 
27 B3B 57 27.9515 1832 1827 isopropyl-
tetradecanoate 
- 2,4-dimethylpentane 
28 B3B 71 29.9932 1930 1927 methyl-
hexadecanoate 
- docosane 
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29 B6B 57 30.4182 1951 1927 methyl-
hexadecanoate 
- - 
30 B10 69 30.5987 1960 1927 methyl-
hexadecanoate 
- - 
31 B4C 73 30.6949 1965 1999 eicosane - - 
32 B6B 71 32.0267  - - 3-hexanone, 
2,2-dimethyl- 
2,2-dimethylbutane 
33 B3B 71 32.0458  - - - 2,2-dimethylbutane 
34 B6B 69 34.1452  - - - docosane 
35 B3B 69 34.7128  - - - - 
36 B4C 69 34.7233  - - - - 
37 B6C 71 35.0713  - - - - 
38 B3C 71 36.7162  - - - 3-ethylpentane 
39 B9B 395 38.2697  - - - - 
40 B6C 71 38.8875  - - - 3-ethylhexane 
41 B6B 71 39.0147  - - - - 
42 B4C 57 39.4792  - - - 3-ethylhexane 
43 B6B 57 39.4822  - - - 3,3-dimethyl-1-
butene 
44 B4C 71 39.6266  - - - 3-ethylpentane 
45 B3C 71 39.7884  - - - - 
46 B6B 57 40.4997  - - 3-hexanone, 
2,2-dimethyl- 
2-methylbutane 
47 B6C 57 40.7684  - - - 3-ethylpentane 
48 B3C 71 40.7722  - - - - 
49 B4C 57 43.09  - - - 3-ethylpentane 
50 B6B 57 43.0982  - - - 2,2,4,6,6-
pentamethylheptane 
51 B6C 85 43.2865  - - - 2-methylnonane 
52 B6B 71 43.3628  - - - 3-ethylpentane 
53 B3C 71 43.3691  - - - - 
54 B3B 85 43.7727  - - - 3,3-dimethyl-1-
butene 
55 B4B 85 44.3901  - - - Amitrole 
56 B6B 71 44.3953  - - - 3-aminopropiononitrile 
57 B4A 71 46.2638  - - - - 
58 B3C 71 46.8143  - - - 2,3-dimethylbutane 
59 B6B 71 46.822  - - 3-hexanone, 
2,2-dimethyl- 
- 
60 B6C 71 47.3544  - - - - 
61 B4A 71 47.7467  - - - 3-ethylypentane 
62 B3A 57 47.7529  - - - 3,3-dimethyl-1-
butene 
63 B4A 71 48.0072  - - - - 
64 B6B 71 48.0159  - - - - 
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65 B6C 71 48.0169  - - - - 
66 B4A 71 48.0321  - - - - 
67 B4B 71 50.7731  - - - - 
Table S4. Compound peaks detected from GC-MS analysis of samples used for evaluation 
of temporal and spatial patterns of non-polar metabolites of three cryptic species of P. 
hornemanni found in the Visayas. Identifications based on comparison of either Kovat’s 
Indices (KI) of compounds retrieved from the Retention Index Calculator [37] or mass 
spectral comparison of compounds retrieved from NIST or MassBase. Asterisk (*) 
indicates compounds with parent ions showing halogenated mass spectral patterns. 
# Sample 
Base 
Peak 
  KI KI Based ID  Mass Spectra Based ID 
   
RT 
 
Nearest KI Lucero et al. [37] Massbase 
1 3A 57 8.1118 1065 1062 y-terpinene undecane 
2 15A 57 14.556 1285 1286 borneol acetate 1-nonene 
3 9A 57 14.556 1285 1286 borneol acetate pentacosane 
4 29A 57 20.3128 1500 1499 a-muurolene tricosane 
5 15B 71 20.5458 1510 1509 β-bisabolene 3-ethylpentane 
6 15A 57 25.186 1705 1686 8-cedren-13-ol - 
7 34A 57 25.4206 1716 1735 oplopanone - 
8 15B 71 26.6674 1772 1761 benzyl-benzoate 2-methylbutane 
9 15A 57 27.8534 1827 1827 isopropyl tetradecanoate 
 10 44BB 71 30.0015 1930 1927 methyl hexadecanoate docosane 
11 8B 57 30.4069 1950 1927 methyl hexadecanoate 
 12 15B 71 31.6111 - - - - 
13 15A 57 31.8326 - - - - 
14 15B 57 31.8342 - - - 1,4-dimethylhexane 
15 44BA 71 34.1535 - - - docosane 
16 15B 71 34.2967 - - - 3-ethylpentane 
17 15A 57 34.76 - - - 1-octene 
18 15A 71 35.4496 - - - 2-methylbutane 
19 15B 57 35.5757 - - - - 
20 15B 57 35.5757 - - - 2,2-dimethylbutane 
21 44BA 71 37.9407 - - - docosane 
22 15B 410 38.2743 - - - - 
23 15A 71 39.3484 - - - 3-ethylhexane 
24 15A 71 40.0877 - - - 2,2-dimethylbutane 
25 15A 71 40.0981 - - - beta-Aminopropionitrile 
26 15B 71 42.5358 - - - 2-methylbutane 
27 15B 57 43.9626 - - - 4-methyloctane 
28 44C 71 44.6454 - - - - 
29 15A 57 45.2255 - - - 2,2-dimethylbutane 
30 15A 71 47.3529 - - - - 
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31 15B 57 47.3534 - - - - 
32 15B 57 47.3581 - - - 2,4-dimethylpentane 
33 15A 71 47.6237 -   -  - 2,4-dimethylhexane 
Figure S1. Map of sampling sites. (a) Map of the Philippines indicating location of 
Batanes and Visayas; (b) Sampling sites in Batan and Sabtang Islands in Batanes;  
(c) Sampling sites in Siquijor, Negros, and Cebu Islands in the Visayas). 
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